• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6802220
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/29/2020
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that higher than expected bhcg ii results were obtained from non-vitros seronorm l1 qc fluid lot 1709896 using vitros immunodiagnostics products bhcg ii reagent lot 2680 in combination with a vitros 5600 integrated system.The assignable cause for the higher than expected vitros bhcg qc fluid results could not be determined with the information provided.Based on historical quality control results, a vitros bhcg lot 2680 performance issue is not a likely contributor to the event.Additionally, there is no indication of an instrument malfunction and unexpected instrument performance is not a likely contributor to the events as precision testing performed on the instrument was within ortho guidelines.Sample handling could not be ruled out as a possible cause of the higher than expected results as the customer was only allowing 5 minutes before loading on the instrument following removal from the refrigerator per the vitros bhcg instructions for use, you should bring samples to room temperature 15¿30 °c (59¿86 °f) before use.Continual tracking and trending of complaints has not identified any signals that would indicate a potential systemic issue with vitros bhcg ii reagent lot 2680.
 
Event Description
A customer contacted the ortho clinical diagnostics (ortho) technical solutions center (tsc) to report higher than expected bhcg ii results obtained from a non-vitros seronorm l1 quality control (qc) fluid, using vitros immunodiagnostics product total b-hcg ii (bhcg) reagent on a vitros 5600 integrated system.Seronorm l1 qc fluid lot 1709896: 12.09 and 9.09 miu/ml versus expected result of 6.00 miu/ml.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.The higher than expected vitros bhcg results were from non-patient fluid.The customer did not give any indication that patient results had been affected.However, the investigation cannot conclude that patient sample results would not be affected if the event were to recur undetected.There is no allegation of patient harm as a result of this event.This report is number 2 of 2 mdr¿s for this event.Two (2) 3500a forms are being submitted for this event as 2 devices were involved.This report corresponds to ortho clinical diagnostics inc.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key10477588
MDR Text Key233927115
Report Number3007111389-2020-00117
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Other
Type of Report Initial
Report Date 09/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/09/2021
Device Catalogue Number6802220
Device Lot Number2680
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 08/07/2020
Initial Date FDA Received09/01/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/27/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-